Contact
Please use this form to send email to PR contact of this press release:
Hudson Therapeutics and Shaperon Engage Major Global Pharmaceutical Companies at BIO-Europe 2024
TO:
Ellie Jung
Hudson Therapeutics, Inc, US Subsidiary of Shaperon